CCG-232964

CAT: 0804-HY-130011Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-130011Size:1 Each
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CCG-232964 is an orally active inhibitor of Rho/MRTF/SRF. CCG-232964 inhibits LPA-induced CTGF gene expression[1].
CAS Number
[2349373-70-0]
UNSPSC
12352005
Target
Ras; ROCK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton; GPCR/G Protein; MAPK/ERK Pathway; Stem Cell/Wnt; TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ccg-232964.html
Solubility
10 mM in DMSO
Smiles
O=C(O)CCCSC1=NN=C(C2=CC=C(C3CC3)C=C2Cl)O1
Molecular Formula
C15H15ClN2O3S
Molecular Weight
338.81
References & Citations
[1]Kahl, Dylan, et al. 5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF) /Serum Reponse Factor (SRF) -Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma. Journal of Medicinal Chemistry, (), acs.jmedchem.8b01772–.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Popular Products